AIIMS, Delhi to hold 2nd session of National Clinical Grand Rounds today

In this handout photo released by the University of Oxford blood samples from coronavirus vaccine trials are handled inside the Jenner Institute in Oxford, England Thursday June 25, 2020. Scientists at Oxford University say their experimental coronavirus vaccine has been shown in an early trial to prompt a protective immune response in hundreds of people who got the shot. In research published Monday July 20, 2020 in the journal Lancet, scientists said that they found their experimental COVID-19 vaccine produced a dual immune response in people aged 18 to 55. (John Cairns, University of Oxford via AP)

All India Institute of Medical Sciences, Delhi will hold the second session of National Clinical Grand Rounds (CGR) today at 3 PM.

The interactive session, which will be led by AIIMS Director, Dr. Randeep Guleria, aims at facilitating insightful discussion on COVID related issues. Senior doctors of the premier health Institute will be discussing on the usage of antiviral and anti-IL6 drugs in moderately severe COVID cases.

Doctors from medical colleges and Senior Physicians from hospitals located across the country and abroad will be participating in the online session.

AIIMS has been extensively involved in managing patients, developing guidelines, policies and research in COVID-19. The medical Institute has managed over 5000 patients of all severity of the disease.

In an effort to share its experience and initiate discussions on management of common issues related to COVID-19, AIIMS Delhi in conjunction with NITI Aayog and Union Health Ministry launched the National Clinical Grand Rounds (CGR) on COVID-19. These sessions include presentation of clinical cases by physicians directly involved in COVID management. Challenges faced in the management are also discussed by a panel of eminent experts from across the country and outside India.